loading

Pyxis Oncology Inc Azioni (PYXS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
100.00%
-
2.82 - - -
Operating Expenses
3.95%
23.46
22.57 22.91 40.07 23.75
Benefits Costs and Expenses
5.32%
22.00
20.89 21.16 37.73 21.20
Costs And Expenses
5.32%
22.00
20.89 21.16 37.73 21.20
Operating Income/Loss
18.79%
-23.46
-19.75 -22.91 -40.07 -23.75
Nonoperating Income/Loss
13.16%
1.458
1.679 1.756 2.334 2.551
Income/Loss From Continuing Operations Before Tax
21.76%
-22.00
-18.07 -21.16 -37.73 -21.20
Income Tax Expense/Benefit
100.00%
-
0.283 - -2.164 -
Income/Loss From Continuing Operations After Tax
19.88%
-22.00
-18.35 -21.16 -35.57 -21.20
Net Income/Loss
19.88%
-22.00
-18.35 -21.16 -35.57 -21.20
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.03%
62.56
61.92 61.05 0.9338 60.72
Diluted Average Shares
1.03%
62.56
61.92 61.05 0.9338 60.72
Basic Earnings Per Share
16.67%
-0.35
-0.30 -0.35 -0.59 -0.35
Diluted Earnings Per Share
16.67%
-0.35
-0.30 -0.35 -0.59 -0.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):